---All---
  • ---All---
  • Accession
  • Catalog #

ZAP-70 Antibody Phospho (pY492)Rabbit Monoclonal Antibody

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AJ1824d 100ul 400 ul 2-3 days $ 355.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

ZAP-70 Antibody Phospho (pY492) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionP43403
ReactivityHuman
Clone NamesEP2291Y
Calculated MW69872 Da
Gene ID 7535
Other Names
ZAP70, SRK, Tyrosine-protein kinase ZAP-70, 70 kDa zeta-associated protein;Syk-related tyrosine kinase
Target/Specificity
A synthetic phospho-peptide corresponding to residues surrounding Tyr492 of human ZAP-70 was used as immunogen. The antibody only detects ZAP-70 phosphorylated on Tyrosine 492.
Dilution
WB~~1:1000~10000
Format
50 mM Tris-Glycine (pH 7.4), 0.15 M NaCl, 40% Glycerol, 0.01% sodium azide and 0.05% BSA.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
ZAP-70 Antibody Phospho (pY492) is for research use only and not for use in diagnostic or therapeutic procedures.

ZAP-70 Antibody Phospho (pY492) - Protein Information

Name ZAP70
Synonyms SRK
Function
Tyrosine kinase that plays an essential role in regulation of the adaptive immune response. Regulates motility, adhesion and cytokine expression of mature T-cells, as well as thymocyte development. Contributes also to the development and activation of primary B-lymphocytes. When antigen presenting cells (APC) activate T-cell receptor (TCR), a serie of phosphorylations lead to the recruitment of ZAP70 to the doubly phosphorylated TCR component CD247/CD3Z through ITAM motif at the plasma membrane This recruitment serves to localization to the stimulated TCR and to relieve its autoinhibited conformation. Release of ZAP70 active conformation is further stabilized by phosphorylation mediated by LCK. Subsequently, ZAP70 phosphorylates at least 2 essential adapter proteins: LAT and LCP2. In turn, a large number of signaling molecules are recruited and ultimately lead to lymphokine production, T-cell proliferation and differentiation Furthermore, ZAP70 controls cytoskeleton modifications, adhesion and mobility of T-lymphocytes, thus ensuring correct delivery of effectors to the APC. ZAP70 is also required for TCR-CD247/CD3Z internalization and degradation through interaction with the E3 ubiquitin-protein ligase CBL and adapter proteins SLA and SLA2 Thus, ZAP70 regulates both T-cell activation switch on and switch off by modulating TCR expression at the T-cell surface. During thymocyte development, ZAP70 promotes survival and cell-cycle progression of developing thymocytes before positive selection (when cells are still CD4/CD8 double negative). Additionally, ZAP70-dependent signaling pathway may also contribute to primary B-cells formation and activation through B-cell receptor (BCR)
Cellular Location
Cytoplasm. Cell membrane; Peripheral membrane protein. Note=In quiescent T-lymphocytes, it is cytoplasmic. Upon TCR activation, it is recruited at the plasma membrane by interacting with CD247/CD3Z. Co-localizes together with RHOH in the immunological synapse. RHOH is required for its proper localization to the cell membrane and cytoskeleton fractions in the thymocytes (By similarity)
Tissue Location
Expressed in T- and natural killer cells. Also present in early thymocytes and pro/pre B-cells

ZAP-70 Antibody Phospho (pY492) - Related products

AP3658a: Phospho-ZAP70-Y319

AP3659a: Phospho-ZAP70-Y492

AP3660a: Phospho-ZAP70-Y493

AP3676a: Phospho-ZAP70-Y292 Antibody

AP7824c: ZAP70 Antibody (Center)

RI15782: ZAP70 predesign siRNA

BP3658a: Phospho-ZAP70-Y319 Blocking Peptide

BP3659a: Phospho-ZAP70-Y492 Blocking Peptide

BP3660a: Phospho-ZAP70-Y493 Blocking Peptide

BP3661a: Phospho-ErbB2-pY1248(M) Blocking Peptide

BP3676a: Phospho-ZAP70-Y292 Antibody Blocking Peptide

BP7824c: ZAP70 Antibody (Center) Blocking Peptide

AO1058a: ZAP70 Antibody

AJ1824a: ZAP-70 Antibody

AJ1824b: ZAP-70 Antibody (C-term)

AJ1824c: ZAP70 Antibody Phospho (pY292)

AJ1824d: ZAP-70 Antibody Phospho (pY492)

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

Zap-70, a Syk-family protein tyrosine kinase, plays a critical role in mediating T cell signal transduction in response to T cell receptor (TCR) activation (1). TCR-mediated activation of the Src-family kinases, Lck and Fyn, results in tyrosine phosphorylation of the TCR zeta and CD3 chains. These domains serve as targets for binding of ZAP-70 via its tandem SH2 domains. This binding correlates with activation of ZAP-70, a critical event in T cell activation (2). Following TCR engagement, ZAP-70 is phosphorylated on several tyrosine residues, presumably by two mechanisms: an autophosphorylation and a trans-phosphorylation by the Src-family tyrosine kinase, Lck. Lck phosphorylates Tyrosine 492 and 493 located at the activation loop of the catalytic domain of ZAP-70, leading to its activation and increased autophosphorylation (3).

REFERENCES

1. Chu, D.H., et al. Immunol. Rev. 165:167
2. Isakov, N., et al. J Exp Med. 181:375
3. Isakov, N., et al. J Exp Med. 181:375